Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1918 Records) |
| Query Trace: Immunotherapy[original query] |
|---|
| Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108051. S Berenice Urtecho, Leonardo Provenzano, Andrea Spagnoletti, Achille Bottiglieri, Chiara Pircher, Giacomo Massa, Caterina Sposetti, Claudia Proto, Marta Brambilla, Mario Occhipinti, Laura Mazzeo, Teresa Beninato, Rita Leporati, Claudia Giani, Chiara Cavalli, Roberta Serino, Marco Meazza Prina, Anna Bassetti, Vincenzo Nasca, Rosa Maria di Mauro, Alice Abate, Sara Manglaviti, Andra Diana Dumitrascu, Giorgia Di Liberti, Teresa Serra Cassano, Monica Ganzinelli, Sulin Wu, Marina Chiara Garassino, Filippo G M de Braud, Giuseppe Lo Russo, Arsela Prel |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy. Cancer research and treatment 2024 12 . Eun Joo Kang, Shinwon Hwang, Yun-Gyoo Lee, Jong-Kwon Choi, Seong Hoon Shin, Yoon Hee Choi, Keun-Wook Lee, Hyun Woo Lee, Min Kyoung Kim, Seung Taek Lim, Hwan Jung Yun, Sang-Gon Park, Sangwoo Kim, Sung-Bae Kim, Hye Ryun K |
| STEAP3 is a potential preliminary prognostic biomarker of glioblastoma. Scientific reports 2024 12 14 (1): 30994. Wenhua Zhang, Meng Xie, Qiang Huang, Honglei Liu, Jianfeng Liu, Xiaoli Sun, Conghui |
| Whole exome-seq and RNA-seq data reveal unique neoantigen profiles in Kenyan breast cancer patients. Frontiers in oncology 2024 12 14 1444327. Godfrey Wagutu, John Gitau, Kennedy Mwangi, Mary Murithi, Elias Melly, Alexandra R Harris, Shahin Sayed, Stefan Ambs, Francis Makok |
| Clinical characteristics and survival outcomes in patients with pulmonary sarcomatoid carcinoma: a multicenter retrospective study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 12 . Zhijuan Du, Yuhui Qin, Yahui Lv, Jie Gao, Siyuan Chen, Xiangyu Du, Tao Li, Yi Hu, Zhefeng L |
| Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration. Frontiers in immunology 2024 12 15 1485358. Du Feng, Huixin Jiang, Gengjia Chen, Wenhui Guan, Lin Yi, Yue Zhu, Yijia Li, Gengda Huang, Bin He, Junlong Tang, Yujie Tang, Jiyuan Zeng, Wensheng Zhou, Jiayu Shi, Zhanhong Xie, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zh |
| STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108058. Andrea De Giglio, Dario De Biase, Valentina Favorito, Thais Maloberti, Alessandro Di Federico, Federico Zacchini, Giulia Venturi, Claudia Parisi, Filippo Gustavo Dall'Olio, Ilaria Ricciotti, Ambrogio Gagliano, Barbara Melotti, Francesca Sperandi, Annalisa Altimari, Elisa Gruppioni, Giovanni Tallini, Francesco Gelsomino, Lorenzo Montanaro, Andrea Ardizzo |
| Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors. Cancer immunology, immunotherapy : CII 2024 12 74 (1): 28. Mina Cho, Hyun Chang, Ju Han K |
| Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study. BMC medicine 2024 12 22 (1): 585. Xue Zhang, Xin Dai, Aina Liu, Meili Sun, Lei Cong, Jing Liang, Zimin Liu, Zhen Li, Jinling Zhang, Jing Lv, Fangli Cao, Linli Qu, Haiyan Liu, Lu Yue, Yi Zhai, Fujun Yang, Jiahui Chu, Shuang Wang, Qian Xu, Jianyuan Zhou, Shulun Nie, Miao Huang, Ruitao Xu, Qiushi Wang, Xinyu Song, Di Zhang, Zhaodi Nan, Song Li, Lian L |
| Cross-talk between cuproptosis and ferroptosis to identify immune landscape in cervical cancer for mRNA vaccines development. European journal of medical research 2024 12 29 (1): 602. Xuchao Zhang, Wenwen Xu, Zi Wang, Jing Liu, Han Gong, Wen Z |
| Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report. EJHaem 2024 12 5 (6): 1243-1251. Jasmine Naru, Megan Othus, ChenWei Lin, Melinda A Biernacki, Marie Bleakley, Thomas R Chauncey, Harry P Erba, Min Fang, Matthew P Fitzgibbon, Phillip R Gafken, Richard G Ivey, Jacob J Kennedy, Travis D Lorentzen, Soheil Meshinchi, Anna Moseley, Era L Pogosova-Agadjanyan, Vivian M Liu, Jerald P Radich, Uliana J Voytovich, Pei Wang, Jeffrey R Whiteaker, Cheryl L Willman, Feinan Wu, Amanda G Paulovich, Derek L Stirewa |
| Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Add |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| Predictive significance of MPT-driven necrosis-related genes signature in gastric cancer and their impact on the tumor microenvironment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 12 . Silan Huang, Lingli Huang, Qi Jiang, Chang Jiang, Guifang G |
| Cathepsin L in Lung Adenocarcinoma: Prognostic Significance and Immunotherapy Response Through a Multi Omics Perspective. Cancer informatics 2024 12 23 11769351241307492. Jianming Lu, Jiaqi Liang, Gang Xiao, Zitao He, Guifang Yu, Le Zhang, Chao Cai, Gao Yi, Jianjiang X |
| Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response. Current medical science 2024 12 44 (6): 1217-1231. Lin Chen, Guo-Zhi Wu, Tao Wu, Hao-Hu Shang, Wei-Juan Wang, David Fisher, Nguyen Thi Thu Hiens, Erkin Musabaev, Lei Zh |
| Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. Cancer management and research 2024 12 16 1759-1773. Sai Te Er Nu Er Lan, Bo Yu, Yan Yang, Yanli Shen, Bing Xu, Yiyi Zhan, Chunling L |
| Development of a centrosome amplification-associated signature in kidney renal clear cell carcinoma based on multiple machine learning models. Computational biology and chemistry 2024 12 115 108317. Zhen Song, Chunlei Xue, Hui Wang, Lijian Gao, Haibin Song, Yuanyuan Ya |
| Next generation sequencing-based MSI scoring predict benefit in mismatch repair deficient tumors treated with nivolumab: follow-up on NCI-MATCH arm Z1D. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, Li Chen, Michael J Overman, Katrina Kao, Latifa F Jackson, Donna Brunnquell, Xiangning Bu, Christina Coppola, Ping Guan, Jennifer Lee, David Sims, Rebecca Fuchs, Jason L Weirather, Kathleen L Pfaff, Lauren Gunasti, Srin Ranasinghe, Stanley R Hamilton, Victoria Wang, Peter J O'Dwyer, Catherine J Wu, Scott J Rodig, David R Patton, Lyndsay Harr |
| Roles of immunoglobulin GM and KM allotypes and Fc? receptor 2?A genotypes in humoral immunity to a conserved microbial polysaccharide in pulmonary diseases. Genes and immunity 2025 1 . Janardan P Pandey, Paul J Nietert, Aryan M Namboodiri, Christine Kimball, Patrick A Flu |
| Prognostic factors in chronic lymphocytic leukaemia - the old, the new and the future. Leukemia & lymphoma 2025 1 1-11. Sean McKeague, Constantine T |
| Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort. JCO global oncology 2025 1 11 e2400353. Ullas Batra, Kumar Prabhash, Vanita Noronha, Ramakant Deshpande, Sachin Khurana, Gull Mohammad Bhat, Rajesh Mistry, Vivek Agarwala, Sajjan Rajpurohit, Bhavesh Poladia, Mansi Sharma, Saquib Zaffar Band |
| Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2025 1 5 (6): 1435-1449. Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, Hélène Blons, Rym BenDhiab, Laure Gibault, Elizabeth Fab |
| A prognostic model for acute myeloid leukemia based on ferroptosis-related lncRNA and immune infiltration analysis. Biophysics reports 2025 1 10 (6): 377-387. Shuhan Liu, Yingli Chen, Qianzhong Li, Zhiyu Fan, Menglan Li, Pengyu |
| Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer. Scientific reports 2025 1 15 (1): 874. Wen Yin, Yanting Ao, Qian Jia, Chao Zhang, Liping Yuan, Sha Liu, Wanmeng Xiao, Gang Luo, Xiaomin Shi, Chen Xin, Maolin Chen, Muhan Lü, Zehui |
| Identification of immune characteristics of two lung adenocarcinoma subtypes based on immune- and pyroptosis-related genes to improve immunotherapy. Bulletin du cancer 2025 1 . Yifan Tie, Jinzhi |
| Overexpression of CHMP2B suppresses proliferation of renal clear cell carcinoma cells. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2025 1 45 (1): 126-136. Xiaorui Chen, Qingzheng Wei, Zongliang Zhang, Jiangshui Yuan, Weiqing So |
| Construction of a cuproptosis-tricarboxylic acid cycle-associated lncRNA model to predict the prognosis of non-small cell lung cancer. Translational cancer research 2025 1 13 (12): 6807-6824. Xiang Li, Yunlong Zhao, Shengjie Wei, Yuqing Dai, Chun |
| Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population. Pathology, research and practice 2025 1 266 155806. Inwoo Hwang, So Young Kang, Deok Geun Kim, Kee-Taek Jang, Kyoung-Mee K |
- Page last reviewed:Feb 1, 2024
- Content source: